Article · 2 Nov 2023
Conference abstractPublished 27 Nov 2013
Usefulness of statin administration before coronary artery bypass grafting
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We have previously reported that atorvastatin and aspirin combined therapy improves accelerated platelet function, vascular endothelial cell function, blood coagulation system, inflammatory and immune responses after coronary artery bypass grafting (CABG). In this study, we compared the effects of atorvastatin plus aspirin combined therapy on inflammatory responses, endothelial cell function, and blood coagulation system in patients undergoing coronary artery bypass grafting (CABG) to aspirin monotherapy. The patients were randomized into two groups in a double-blind trial. One group (n=15) received atorvastatin (10 mg) plus aspirin (100 mg) (combined therapy group) and the other group (n=16) received aspirin (100 mg) alone (monotherapy group). Reduced total cholesterol in the combined therapy group was found in a short term of medication for 14 days. On postoperative day (POD)-14, inhibitory effects of the combined therapy on platelet-rich plasma (PRP) and whole blood (WB) aggregation as well as platelet activation assessed by flow cytometry were stronger than those of the monotherapy. Furthermore, cytokine, cytokine receptors, c-reactive protein and α 1-acid glycoprotein in the combined therapy group were down-regulated on POD-14. At the same time, circulating levels of thromboxane A2, vascular endothelial growth factor and thrombin-antithrombin III complex as well as P-selectin, L-selectin and intercellular adhesion molecule-1 were down-regulated, while E-selectin and transforming growth factor- β 1 was up-regulated. Atorvastatin plus aspirin combined therapy may improve inflammatory responses, accelerated platelet function, vascular endothelial cell function, blood coagulation system at the early stage such as 14 th day after CABG. In conclusion, atorvastatin and aspirin combined therapy may bring beneficial effects to the patient after CABG.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 11 Jan 2023
Clinical Efficacy of Atorvastatin Combined with Ezetimibe in Preventing Restenosis after Coronary Artery Bypass Grafting
Research article · 24 Mar 2021
Efficacy of Local Vancomycin Application in Prevention of Poststernotomy Wound Infection in High-Risk Coronary Artery Bypass Grafting Patients
Research article · 31 Jan 2020
Evaluation of Cognitive Behavior Combined with Biofeedback Therapy Based on the Fusion of Normed Space and Banach Space on the Emotional State of Patients with Coronary Artery Bypass Grafting
Research article · 3 May 2019
Effect of general anesthesia plus spinal anesthesia on patients hemodynamic during coronary artery bypass Grafting surgery
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Research article · 27 Jul 2026
Qualitative LC/MS Assessment of Fenfluramine Hydrochloride After Dilution in Purified Water : A Preliminary Study and Case Report
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Kazuo Nakamura”
